Metacam

Metacam solution is a non-steroidal anti-inflammatory drug (NSAID) for use in cattle and pigs. Each ml of the solution for injection contains 20 mg meloxicam and 150 mg ethanol (as preservative).

Metacam solution is a non-steroidal anti-inflammatory drug (NSAID) for use in cattle and pigs. Each ml of the solution for injection contains 20 mg meloxicam and 150 mg ethanol (as preservative).

Cattle: For use in acute respiratory infection with appropriate antibiotic therapy to reduce clinical signs in cattle. For use in diarrhoea, in combination with oral rehydration therapy, to reduce clinical signs in calves of over one week of age and young non-lactating cattle.For adjunctive therapy in the treatment of acute mastitis, in combination with antibiotic therapy.

Pigs: For use in non-infectious locomotor disorders to reduce the symptoms of lameness and inflammation. For adjunctive therapy in the treatment of puerperal septicaemia and toxaemia (mastitis metritisagalactia syndrome) with appropriate antibiotic therapy.

Directions to use Metacam

Cattle: Single subcutaneous or intravenous injection at a dose rate of 0.5mg meloxicam/kg bodyweight (i.e. 2.5 ml/100 kg bodyweight) in combination with antibiotic therapy or with oral rehydration therapy as appropriate.

Pigs: Single intramuscular injection at a dosage of 0.4 mg meloxicam/kg bodyweight

(i.e. 2.0ml/100kg bodyweight) in combination with antibiotic therapy, as appropriate. If required, a second administration of meloxicam can be given after 24 hours.

Do not use in animals suffering from impaired hepatic, cardiac or renal function and haemorrhagic disorders, or where there is evidence of ulcerogenic gastro-intestinal lesions or individual hypersensitivity to the product.  For the treatment of diarrhoea, do not use in animals less than one week of age.

Do not administer concurrently with glucocorticosteroids, other non-steroidal anti-inflammatory drugs or with anti-coagulant agents.

Avoid use in very severely dehydrated, hypovolaemic or hypotensive animals which require parenteral

rehydration, as there may be a potential risk of increased renal toxicity.

Subcutaneous, intramuscular as well as intravenous administration is well tolerated; only a slight transient selling at the injection site following subcutaneous administration was observed in less than 10% of the cattle treated in clinical studies.

In case of overdosage, symptomatic treatment should be initiated.